HARVARD BIOSCIENCE INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Harvard Bioscience Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Harvard Bioscience Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $4.42M, a 15.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.42M -$833K -15.9% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.36M -$1.15M -20.8% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $4.77M -$1.04M -17.9% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $5.06M -$958K -15.9% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $5.25M -$983K -15.8% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $5.51M -$1.1M -16.7% Mar 31, 2023 10-Q 2023-04-26
Q4 2022 $5.82M -$1.08M -15.7% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $6.02M -$1.06M -15% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $6.24M -$1.01M -13.9% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $6.61M -$803K -10.8% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $6.9M -$864K -11.1% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $7.08M -$846K -10.7% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $7.24M -$924K -11.3% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $7.41M -$719K -8.85% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $7.76M -$702K -8.3% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $7.93M -$570K -6.71% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $8.17M -$681K -7.7% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $8.13M -$979K -10.8% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $8.46M +$8.46M Dec 31, 2019 10-K/A 2021-03-17
Q3 2019 $8.5M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $8.85M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $9.11M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $0 Dec 31, 2018 10-Q 2019-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.